Natera (45E) Stock Forecast & Price Target

4 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

45E Analyst Ratings

Strong Buy

17 Buy

2 Hold

0 Sell

Based on 19 analysts giving stock ratings to

Natera

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

45E Stock 12 Month Forecast

Average Price Target

€235.32

▲(42.32% Upside)

Based on 19 Wall Street analysts offering 12 month price targets for Natera in the last 3 months. The average price target is €235.32 with a high forecast of €271.82 and a low forecast of €192.91. The average price target represents a 42.32% change from the last price of €165.35.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"157":"€157","272":"€272","185.75":"€185.8","214.5":"€214.5","243.25":"€243.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":271.8234783,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€271.82</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":235.32459996375,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€235.32</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":192.9069846,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€192.91</span>\n  </div></div>","useHTML":true}}],"tickPositions":[157,185.75,214.5,243.25,272],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,235.9,238.66334448461538,241.42668896923078,244.19003345384615,246.95337793846153,249.71672242307693,252.4800669076923,255.24341139230768,258.0067558769231,260.7701003615384,263.5334448461538,266.29678933076923,269.0601338153846,{"y":271.8234783,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,235.9,235.85573845875,235.81147691750002,235.76721537625,235.722953835,235.67869229375,235.6344307525,235.59016921125,235.54590767,235.50164612875,235.4573845875,235.41312304624998,235.36886150499998,{"y":235.32459996375,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,235.9,232.59284496923078,229.28568993846153,225.9785349076923,222.67137987692308,219.36422484615383,216.0570698153846,212.74991478461538,209.44275975384613,206.1356047230769,202.8284496923077,199.52129466153843,196.2141396307692,{"y":192.9069846,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":158,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":158,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":158,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":158,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":158,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":158,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":197,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":191,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":174,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":172,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":164.4,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":190.4,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":235.9,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€271.82

Average Price Target€235.32

Lowest Price Target€192.91

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Subbu Nambi

Guggenheim

€236.75→€254.29

Buy

53.79%

Upside

Reiterated

06/29/26

Natera price target raised to $290 from $270 at GuggenheimNatera price target raised to $290 from $270 at Guggenheim

Eve Burstein

Bernstein

€271.82

Buy

64.39%

Upside

Initiated

06/25/26

Bernstein Initiates a Buy Rating on Natera (NTRA)

William Bonello

Craig-Hallum

―

Buy

―

Reiterated

06/24/26

Analysts Offer Insights on Healthcare Companies: Verastem (NASDAQ: VSTM), Natera (NASDAQ: NTRA) and Vera Therapeutics (NASDAQ: VERA)

Luke Sergott

Barclays

€245.52→€227.98

Buy

37.88%

Upside

Assigned

06/24/26

Barclays Sticks to Its Buy Rating for Natera (NTRA)

Evie Koslosky

Goldman Sachs

€214.83

Hold

29.92%

Upside

Reiterated

06/24/26

Natera: Japan Signatera Opportunity Balanced by Valuation; Hold Rating Reiterated, $245 Price Target Maintained

David Westenberg

Piper Sandler

€218.34

Buy

32.04%

Upside

Reiterated

06/23/26

Natera (NTRA) Gets a Buy from Piper Sandler

Kyle Mikson CFA

Canaccord Genuity

€249.9

Buy

51.14%

Upside

Reiterated

06/23/26

Analysts Offer Insights on Healthcare Companies: CG Oncology, Inc. (NASDAQ: CGON), Natera (NASDAQ: NTRA) and Pfizer (NYSE: PFE)

Mark Massaro

BTIG

€236.75

Buy

43.18%

Upside

Reiterated

06/23/26

Analysts Are Bullish on These Healthcare Stocks: Hinge Health, Inc. Class A (HNGE), Natera (NTRA)

Puneet Souda

Leerink Partners

―

Buy

―

Reiterated

06/22/26

NCCN guidelines may be meaningful catalyst for Natera, says LeerinkNCCN guidelines may be meaningful catalyst for Natera, says Leerink

Dan Leonard

RBC Capital

€241.13

Buy

45.83%

Upside

Initiated

06/11/26

Natera resumed with an Outperform at RBC CapitalNatera resumed with an Outperform at RBC Capital

Patrick B Donnelly

Citi

€263.05

Buy

59.09%

Upside

Reiterated

05/28/26

Citi Remains a Buy on Natera (NTRA)

Kallum Titchmarsh

Morgan Stanley

€219.21

Buy

32.57%

Upside

Reiterated

05/12/26

Morgan Stanley Remains a Buy on Natera (NTRA)

Brandon Couillard

Wells Fargo

€188.52→€192.91

Hold

16.67%

Upside

Reiterated

05/08/26

Natera price target raised to $220 from $215 at Wells FargoNatera price target raised to $220 from $215 at Wells Fargo

Andrew Brackmann

William Blair

―

Buy

―

Reiterated

05/08/26

Analysts Offer Insights on Healthcare Companies: Guardant Health (NASDAQ: GH), ImageneBio (NASDAQ: IMA) and Natera (NASDAQ: NTRA)

Catherine Ramsey Schulte

Robert W. Baird

€225.35→€232.37

Buy

40.53%

Upside

Reiterated

05/08/26

Natera price target raised to $265 from $257 at BairdNatera price target raised to $265 from $257 at Baird

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Subbu Nambi

Guggenheim

€236.75→€254.29

Buy

53.79%

Upside

Reiterated

06/29/26

Natera price target raised to $290 from $270 at GuggenheimNatera price target raised to $290 from $270 at Guggenheim

Eve Burstein

Bernstein

€271.82

Buy

64.39%

Upside

Initiated

06/25/26

Bernstein Initiates a Buy Rating on Natera (NTRA)

William Bonello

Craig-Hallum

―

Buy

―

Reiterated

06/24/26

Analysts Offer Insights on Healthcare Companies: Verastem (NASDAQ: VSTM), Natera (NASDAQ: NTRA) and Vera Therapeutics (NASDAQ: VERA)

Luke Sergott

Barclays

€245.52→€227.98

Buy

37.88%

Upside

Assigned

06/24/26

Barclays Sticks to Its Buy Rating for Natera (NTRA)

Evie Koslosky

Goldman Sachs

€214.83

Hold

29.92%

Upside

Reiterated

06/24/26

Natera: Japan Signatera Opportunity Balanced by Valuation; Hold Rating Reiterated, $245 Price Target Maintained

David Westenberg

Piper Sandler

€218.34

Buy

32.04%

Upside

Reiterated

06/23/26

Natera (NTRA) Gets a Buy from Piper Sandler

Kyle Mikson CFA

Canaccord Genuity

€249.9

Buy

51.14%

Upside

Reiterated

06/23/26

Analysts Offer Insights on Healthcare Companies: CG Oncology, Inc. (NASDAQ: CGON), Natera (NASDAQ: NTRA) and Pfizer (NYSE: PFE)

Mark Massaro

BTIG

€236.75

Buy

43.18%

Upside

Reiterated

06/23/26

Analysts Are Bullish on These Healthcare Stocks: Hinge Health, Inc. Class A (HNGE), Natera (NTRA)

Puneet Souda

Leerink Partners

―

Buy

―

Reiterated

06/22/26

NCCN guidelines may be meaningful catalyst for Natera, says LeerinkNCCN guidelines may be meaningful catalyst for Natera, says Leerink

Dan Leonard

RBC Capital

€241.13

Buy

45.83%

Upside

Initiated

06/11/26

Natera resumed with an Outperform at RBC CapitalNatera resumed with an Outperform at RBC Capital

Patrick B Donnelly

Citi

€263.05

Buy

59.09%

Upside

Reiterated

05/28/26

Citi Remains a Buy on Natera (NTRA)

Kallum Titchmarsh

Morgan Stanley

€219.21

Buy

32.57%

Upside

Reiterated

05/12/26

Morgan Stanley Remains a Buy on Natera (NTRA)

Brandon Couillard

Wells Fargo

€188.52→€192.91

Hold

16.67%

Upside

Reiterated

05/08/26

Natera price target raised to $220 from $215 at Wells FargoNatera price target raised to $220 from $215 at Wells Fargo

Andrew Brackmann

William Blair

―

Buy

―

Reiterated

05/08/26

Analysts Offer Insights on Healthcare Companies: Guardant Health (NASDAQ: GH), ImageneBio (NASDAQ: IMA) and Natera (NASDAQ: NTRA)

Catherine Ramsey Schulte

Robert W. Baird

€225.35→€232.37

Buy

40.53%

Upside

Reiterated

05/08/26

Natera price target raised to $265 from $257 at BairdNatera price target raised to $265 from $257 at Baird

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

TRAXFirst Tracks Biotherapeutics Inc

EVMNEvommune, Inc.

MPLTMapLight Therapeutics, Inc.

MAZEMaze Therapeutics, Inc.

AAPGAscentage Pharma Group International Unsponsored ADR

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Natera

3 Months

William BonelloCraig-Hallum

Success Rate

10/13 ratings generated profit

Average Return

+8.95%

Copying William Bonello's trades and holding each position for 3 Months would result in 76.92% of your transactions generating a profit, with an average return of +8.95% per trade.

1 Year

Daniel BrennanTD Cowen

Success Rate

19/19 ratings generated profit

Average Return

+59.25%

Copying Daniel Brennan's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +59.25% per trade.

2 Years

Daniel BrennanTD Cowen

Success Rate

19/19 ratings generated profit

Average Return

+106.29%

Copying Daniel Brennan's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +106.29% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

45E Analyst Recommendation Trends

Rating

Mar 26

Apr 26

May 26

Jun 26

Jul 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, 45E has received 21 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. 45E average Analyst price target in the past 3 months is 235.32.

Each month's total comprises the sum of three months' worth of ratings.

45E Financial Forecast

45E Earnings Forecast

Next quarter’s earnings estimate for 45E is -€0.43 with a range of -€0.67 to -€0.26. The previous quarter’s EPS was -€0.53. 45E beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year 45E has Performed in-line its overall industry.

45E Sales Forecast

Next quarter’s sales forecast for 45E is €579.61M with a range of €567.85M to €600.03M. The previous quarter’s sales results were €610.85M. 45E beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year 45E has Performed in-line its overall industry.

45E Stock Forecast FAQ

What is DE:45E’s average 12-month price target, according to analysts?

Based on analyst ratings, Natera Inc.’s 12-month average price target is 235.32.

What is DE:45E’s upside potential, based on the analysts’ average price target?

Natera Inc. has 42.32% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Natera Inc. a Buy, Sell or Hold?

Natera Inc. has a consensus rating of Strong Buy, which is based on 17 buy ratings, 2 hold ratings and 0 sell ratings.

What is Natera Inc.’s share price target?

The average share price target for Natera Inc. is 235.32. This is based on 19 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €271.82 ,and the lowest forecast is €192.91. The average share price target represents 42.32% Increase from the current price of €165.35.

What do analysts say about Natera Inc.?

Natera Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 19 Wall Streets Analysts.

How can I buy shares of Natera Inc.?

To buy shares of DE:45E, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Natera (45E) Stock Forecast & Price Target

45E Analyst Ratings

45E Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Natera

45E Analyst Recommendation Trends

45E Financial Forecast

45E Earnings Forecast

45E Sales Forecast

45E Stock Forecast FAQ

Detailed List of Analyst Forecasts